Amyris (AMRS) is an industrial biotechnology company. It genetically engineers yeast, so that instead of producing alcohol when it ferments, yeast produces other valuable chemicals instead.

Depending on their goals, engineers at Amyris can outfit the yeast with a variety of genetic material that tells the yeast how to digest what it is fed. The result is a cell that can (at least in ...

Depending on their goals, engineers at Amyris can outfit the yeast with a variety of genetic material that tells the yeast how to digest what it is fed. The result is a cell that can (at least in ...

For decades, Chinese hamster ovary (CHO) cell lines have been ... the economics of drug production. Amyris cut its teeth engineering metabolic pathways in yeast to produce advanced biofuels ...

Amyris's grant share as of January 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents. A recent patent application (Publication Number: US20240035061A1) ...

The researchers created the yeast-based cell factories by inserting a large ... J.D.K. also has financial interests in Amyris, Lygos, Demetrix, Napigen, Apertor Pharmaceuticals, Maple Bio, Ansa ...

Yeast cells can sometimes reverse the protein misfolding and clumping associated with diseases such as Alzheimer's, according to new research from the University of Arizona. The new finding ...